Posted April 4, 2013

FDA Warns Consumers Of Weight Loss Supplement Containing Undeclared Drug

On April 4, 2013, the FDA warned consumers not to purchase or use the dietary supplement MAXILOSS Weight Advanced Blue because it was found to contain sibutramine.

Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.

Consumers who have purchased this supplement should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA’s MedWatch Adverse Event Reporting Program.

MAXILOSS Weight Advanced Blue also contains lotus leaf, jobstears, bamboo shoots, tarragon, green tea, pysllium husk, ginseng and chromium picolinate. It was promoted as a natural herb for weight loss and sold on various websites, including www.extremevitaminworld.com and www.dreamlifeweightloss.com.

Similarly, MAXILOSS Weight Advanced softgels, packaged in a green box, were recalled in February 2013 after they were discovered to contain sibutramine.

See ConsumerLab.com’s Review of Weight Loss Supplements, Ginseng Supplements, and Chromium Supplements for tests of related products.

See Related Warnings:

Weight Loss Supplement Recalled Due To Undeclared Drug

FDA Seizes Weight Loss Supplements Containing Undeclared Drug

Rx Drugs Found in Weight Loss and Enhancement Supplements

Recall of "Slimming" Supplements Spiked with Drug

For more information about this recall, use the link below.